Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 14, 2026 | HealthPartners | Oncology testing: cancer screening and surveillance – retire 06/30/2026PayerPolicy · HEALTHPARTNERS-CC-ENTRY-290047 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology testing: algorithmic assays – Minnesota Health Care Programs – retire 06/30/2026PayerPolicy · HEALTHPARTNERS-CC-ENTRY-261028 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - polatuzumab Vedotin-piiq (Polivy) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-233978 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-233979 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - nivolumab (Opdivo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231697 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - isatuximab-irfc (Sarclisa) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231645 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - fam-trastuzumab deruxtecan-nxki (Enhertu) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-226852 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - daratumumab and daratumumab hyaluronidase-fihj (Darzalex and Darzalex Faspro) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231699 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - caplacizumab-yhdp (Cablivi)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-210231 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - brentuximab vedotin (Adcetris) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231701 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - asparaginase Erwinia chryanthemi (Erwinaze) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231702 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla), fam-trastuzumab deruxtecan-nxki (Enhertu), pertuzumab (Perjeta)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-203715 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Omadacycline (Nuzyra) – Minnesota Healthcare ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-217831 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Ocular anti-VEGF medicationsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-223233 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Oral and enteral nutrition - MinnesotaPayerPolicy · HEALTHPARTNERS-CC-ENTRY-279618 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Medically necessary/ medical necessityPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046042 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Medical injectable medication quantity and frequency limitation coveragePayerPolicy · HEALTHPARTNERS-CC-ENTRY-222431 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Ketamine infusionPayerPolicy · HEALTHPARTNERS-CC-ENTRY-232309 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Investigational services - list of non-covered servicesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046292 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Investigational servicesPayerPolicy · HEALTHPARTNERS-CC-ENTRY-182851 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: respiratoryPayerPolicy · HEALTHPARTNERS-CC-ENTRY-282610 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: dermatologyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-282390 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Implanted and percutaneous peripheral nerve stimulation for treatment of painPayerPolicy · HEALTHPARTNERS-CC-ENTRY-232628 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Home phototherapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045953 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Home health service benefits – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-287851 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Hematopoietic stem cell mobilizersPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046421 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Hemangioma treatmentPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045947 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Heart failure pressure sensor, implantable (i.e., CardioMEMS HF System)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046438 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Health educationPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045940 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gynecomastia surgeryPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046240 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Growth hormone drugs - WisconsinPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046308 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Golodirsen (Vyondys 53) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-226911 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Glucose testing supplies – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-223031 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Glucose testing suppliesPayerPolicy · HEALTHPARTNERS-CC-ENTRY-229035 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for spinal muscular atrophy (Zolgensma, Ivitsma)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-214055 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for dystrophic epidermolysis bullosa (Vyjuvek, Zevaskyn)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-267698 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for aromatic L-amino acid decarboxylase deficiency (Kebilidi)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-284475 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Gender-affirming care, non-surgical – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-261229 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Fosdenopterin (Nulibry)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-235031 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Fabry disease enzyme replacement therapy: agalsidase agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187817 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Eyewear – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045918 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Eyewear for medical conditionsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045916 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Eye surgery - refractivePayerPolicy · HEALTHPARTNERS-CC-AENTRY-045915 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Evinacumab-dgnb (Evkeeza)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-234244 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Etelcalcetide (Parsabiv) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-202922 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Electric tumor treatment fields (ETTF) to treat glioblastoma (Optune) - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-194833 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Electric tumor treatment fields (ETTF) to treat glioblastoma (Optune)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-045903 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Elapegademase-lvlr (Revcovi)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-210228 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Early intensive developmental and behavioral intervention (EIDBI) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-266466 | Criteria changed |
|---|
| May 14, 2026 | HealthPartners | Donanemab-azbt (Kisunla) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-286110 | Criteria changed |
|---|